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Thank you for that kind introduction.  It’s a pleasure and a privilege to represent Battelle at this 
prestigious Conference. 
 
So far you’ve heard – in exquisite detail, I expect – a number of presentations regarding the 
value of university-based research to the processes of commercialization and economic 
development.  My hope here is to give you some additional information about our university-
based research relationships, and augment that with some insight from our work with national 




Before I share some observations and anecdotes about our experience with moving technology 
toward the marketplace, I’d like to give my comments some context and – for those of you who 
may not know much about us – briefly describe Battelle. 
 
Simply put, we’re a global science and technology enterprise that explores emerging areas of 
science, develops and commercializes technology, and manages laboratories for customers.  Here 
are some key items of interest: 
   2
•  We’re a non-profit 501(c)(3) charitable trust formed in 1925; 
•  Our research and development activity totaled $3.8 billion in 2006; 
•  We oversee more than 20,000 employees world-wide, including the national labs we 
manage or co-manage; 
•  We’re involved with more than 5,000 projects for about 1,500 industrial and government 
clients; and  
•  We return a minimum of 20 percent of our profits to the community to meet our 
obligations as a charitable trust – the remainder is re-invested. 
 
Our business is organized into three distinct segments: 
 
•  Laboratory Operations, which include the five national labs we manage or co-manage for 
the U.S. Department of Energy (Pacific Northwest National Laboratory; Brookhaven 
National Laboratory; Oak Ridge National Laboratory; National Renewable Energy 
Laboratory; and Idaho National Laboratory).  These are focused on discovery but all 
provide user facilities and access to unique experimental tools including two of the five 
national nano-science facilities and light sources; 
 
•  Research and Development – now called Battelle Science and Technology International – 
in which we apply science and technology to challenges in areas like homeland security, 
life sciences and infectious diseases, and energy, environment, and advanced 
nanomaterials; and 
 
•  Battelle Ventures, an independent venture fund, which helps move technology into the 
marketplace and develops spin-out ventures as part of our overall business portfolio. 
 
Battelle isn’t an ubiquitous name – we don’t manufacture household commodities, and you 
won’t see our name on consumer products, but we’re behind a number of the technologies and 
items you see in the marketplace.  One of the best-known examples involved independent 
inventor Chester Carlson, Battelle, and a company called Haloid.  They collaborated to develop a   3
process called “xerography” which, of course, led to the office copier machine and the Xerox 
Corporation. 
 
Other Battelle innovations include: 
 
•  Fuel rods for the Nautilus – the world’s first nuclear-powered submarine; 
•  Pioneering work on the technology that led to the compact disc; 
•  Fiber optic advancements for telecommunications; 
•  Medical equipment such as high-efficiency inhalation devices to treat pulmonary 
diseases; 
•  Holograms for credit cards and metal sandwich coins for the U.S. Mint; 
•  A variety of new materials and chemicals from renewable and non-petroleum sources 
such as soybeans; and 
•  High-tech innovations for Operation Desert Storm. 
 
The Case for Collaboration: National Labs and Universities 
 
That’s a “snapshot” of Battelle and a few examples of practical technology-based innovations 
we’ve helped bring to the marketplace.  True innovations, of course, almost never occur in a 
vacuum.  That’s why, throughout our history, many Battelle innovations have come about 
through our alliances in both industry and academia. 
 
Many good things can, and do, occur through collaboration.  But before the real work can begin, 
common ground between the collaborators must be established.  And reaching that common 
ground often requires a change, or at least a compromise, in what are sometimes very different 
organizational cultures and values.  
 
Many of the failure modes experienced by Battelle in venturing and by me earlier in my 
professional life stem from not understanding these interfacial cultural dynamics.  Let me briefly 
explain.  From my vantage point as the CEO, Battelle consists of three distinct cultures:  the first 
culture is one of scientific discovery – often curiosity-driven, conspicuous in the national labs,   4
and very similar to good research universities in many ways.  Contemporary knowledge 
regarding market needs, time-to-market, or costs to scale up is often not cultivated or even 
necessarily valued.  The “coin of the realm” is frequently peer recognition, peer-reviewed 
publications, research grants, facilities, etc.  Patents, so-called directed research, or opportunities 
to leave tenure or the institution for a risky start-up tend to be less desirable options for most of 
the research staff or faculty who are already living their life’s dream. 
 
The second culture at Battelle is one of product-development.  Here, it is the delivery of a 
mission-critical solution on time and on budget to customers or collaborators who care that turns 
their emotional or professional “crank.”  The coin of the realm, in this culture, is teamwork, and 
an ability to integrate ideas from any source to solve interesting and practical problems.  These 
staff are often willing to let others define the problem for them while they focus on delivering the 
unexpected solution. 
 
The third distinct culture has to do with venturing and commercialization.  I will describe our 
experiences in more detail shortly.  Suffice it to say, this culture values ideas only if they can be 
used to solve a real market need, in a timely fashion, for someone willing to pay for the distinct 
economic advantage it provides.  Economic return on one’s investment is the true “coin.”  Often, 
it is organizational leadership and knowledge of the markets being served more than the 
technology per se that is most important to success in this culture. 
 
Hence, I consider my real title at Battelle to be the “CCC,” or the Chief Culture Cop, as much as 
being the CEO! 
 
Before I describe how we deal with these issues in a constructive manner, let me share a telling 
example of culture that comes from Oak Ridge National Laboratory – and which implies that 
these cultural norms are long-lived and hard to change.   
 
In 1960, a group of Oak Ridge National Laboratory scientists developed an instrument to study 
charged particles from the atomic nucleus.  It wasn’t long before scientists at other universities 
and research centers began asking ORNL to supply them with their own detectors, which ORNL   5
chose not to do.  As a result, a group of ORNL employees formed Oak Ridge Technical 
Enterprises Corporation (ORTEC) to produce the instruments, and the company went on to 
succeed beyond what any of the original members could have imagined. 
 
Looking back on the experience, Hal Schmitt, a retired nuclear physicist from ORNL and one of 
ORTEC’s founders, identified the barrier that in some circles is still an obstacle to 
commercialization.  Schmitt said, “There was a kind of underlying attitude that said, in effect, 
any association by a scientific researcher with the business world was crass, and, basically, was 
to be avoided.”       
 
Fortunately, most national labs and universities have since embraced the practical application of 
research through technology transfer and commercialization.  As a result, labs and universities 
contribute to our quality of life and economic competitiveness, generate high-quality research 
and intellectual property, and participate with their industry partners in the resulting revenue 
stream. 
 
Commercialization: the “Rules of Engagement” 
 
Now – what do we see as the “rules of engagement” for laboratories, universities, economic 
development entities, and others who want to commercialize technology? 
 
First, it’s necessary to recognize the three “engines” of innovation – intellectual, commercial, 
and venture.  The intellectual “engines,” or sources of ideas and intellectual property, include 
national laboratories, universities, and research alliances.  The conversion “engines,” which 
translate ideas into prototypes or processes, are typically organizations like Battelle or other 
industrial partners that specialize in “applied” science.  And commercial “engines,” like Battelle 
Ventures, determine contemporary marketplace potential and begin the commercialization 
process. 
 
Second, understand that no organization or university is an island.  Whether developing 
breakthrough products, launching new companies, or stimulating economic development,   6
collaboration is essential.  Remember that innovations frequently come from unexpected sources, 
especially in a technology-driven, knowledge-based economy.  Pay attention to where science 
and technology, economic development, and the market intersect – and never underestimate the 
potential value of those “intersections.”  For example, some consider the interface between ultra-
high speed computing and systems biology as the key to transforming an observation-based 
science like biology into a predictive-based science akin to the transformation of the physical 
sciences in the last century.  If true, the treatment of human disease will move from a focus on 
populations of people to individuals to cellular mechanics with commensurate changes in 
products, delivery systems, and outcomes. 
 
Third, acknowledge that multi-organizational synergy – especially industry-university 
collaboration – is crucial to the process.  Even though we often help bridge the gap between 
business and university research, Battelle still needs collaborators.  For example, we established 
a limited liability company – Brookhaven Science Associates, LLC – with SUNY Research 
Foundation and Stony Brook University through which we co-manage Brookhaven National 
Laboratory.  Such alliances, which also include the major Northeast research universities, can 
support regional and nationwide resources like Brookhaven’s National Synchrotron Light Source 
with its applications in nanoscience, advanced materials, medicine, and biology.  It’s also 
available as a user facility for both university and industrial research. 
 
Of the many lessons we have learned as part of the commercialization process from national 
laboratories and universities, there are perhaps three that have emerged as the most important. 
 
The first lesson has to do with devising strategies for lab-based intellectual property that 
demonstrate the viability of the concept.  I’ll use a football analogy to show how moving from 
the idea stage to the market means surviving the so-called “Valley of Death” of innovation. 
 
Imagine the commercialization process taking place on a football field.  Up to the 20 yard line is 
where most government-funded IP – including university research – starts out as a seminal idea.  
From the 50 yard line to the “goal line” of financial success is where working prototypes are 
developed and industrial team-mates “move the ball” by funding the technology and the   7
economically viable innovations.  The critical gap, or the “Valley of Death,” is between the 
delivery of IP at the 20 yard line, and the “proof of concept” at the 50 yard line.  Without a good 
game plan, you’ll never make it to mid-field, let alone the end zone. 
 
The second lesson has to do with reaching the limit of your expertise and knowing when you 
need help.  Universities and labs – and for that matter, R&D organizations like Battelle – 
typically can’t operate and succeed like venture capitalists without assistance.  They tend to 
overestimate the value of the IP to others, underestimate the time-to-profitability, and have 
limited understanding of or access to broad networks leading to viable marketing and 
experienced business leaders.     
 
The third concerns leadership – we’ve found that tested leadership in the venture area is often 
more important than the technology itself.  An experienced leader can analyze market potential 
without “ownership” issues compromising his/her objectivity, attract “other people’s money” – 
especially for early “seed” investments, and can sell the idea to investors and potential acquirers. 
 
The Role of Battelle Ventures 
 
Let me now share some lessons Battelle and I have learned along this journey from “ideas to 
money.” 
 
Beginning in 1996, Battelle embarked on a concerted effort to spin-out venture-backed 
companies based on Battelle-owned technologies.  An internally staffed organization was 
established to select, nurture, and sell the resulting set of companies – now referred to as 
Portfolio I.  The experience base and governance structure was not unlike that used by many 
university tech transfer departments or even large for-profit companies.  While not a disaster, 
Portfolio I fell short of our expectations for the following reasons: 
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•  Internal staff had limited connectivity to the external venture capital networks which in 
turn restricted deal flow, sources of capital, and access to or knowledge of potential 
acquirers; 
 
•  The technology was overvalued and the role of industry-savvy business leadership was 
undervalued; 
 
•  Other people’s money was not leveraged properly, which kept Battelle’s ownership 
above 85 percent of total equity – an unnecessarily high financial risk; and 
 
•  Limited market knowledge and experience obscured true market valuations. 
 
So, upon my arrival in 2001, we stabilized Portfolio I, and started a second seed and early stage 
fund, now called Battelle Ventures I, by recruiting nationally-known experts to operate it for us. 
 
Although we’re very familiar with technology development, we needed some “adult supervision” 
from those who were more knowledgeable about what might or might not work in the 
marketplace.  We also ensured the governance structure adhered to standards in the top quartile 
early funds. 
 
Battelle Ventures I is a $150 million investment fund which – although independent of Battelle – 
provides seed and start-up capital primarily to businesses that will benefit from technology 
Battelle owns, controls, or influences.  When considering an investment opportunity, Battelle 
Ventures looks for: 
 
•  Proprietary technology that solves a real problem; 
•  Management with industry-relevant experience; 
•  A large, growing, and verifiable market; and 
•  Measurable milestones. 
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Like any experienced venture investor, the Battelle Ventures process tries to avoid the “Valley of 
Death” I mentioned a moment ago by demanding answers to questions like: 
 
•  Who’s the customer? 
•  What is the problem they need to solve? 
•  How is the problem being addressed currently? 
•  How can BMI technology solve their problem significantly better? 
•  What’s the “value proposition”? 
•  Is there a company formed to commercialize? 
•  If so, is the management experienced in the market? 
•  Is there a valid business model and “go-to-market” strategy? 
    
The answers to these questions will suggest what course of action is most appropriate: “spinning-
out” the technology; working with current Battelle or laboratory licensees; or “injecting” new 
technology through strategic partnerships or alliances or contract R&D partnerships. 
 
But perhaps most surprising to most researchers is the time dimension.  Battelle Ventures, as a 
seed and early investing fund, finds that liquidation of a successful investment occurs on average 
around five to seven years after the first investment.  Given our focus on opportunities capable of 
yielding $100M or more upon sale, a portfolio company should be realizing at least $20M or 
more in revenue at the time of sale.  Working backward from, say, a sale of the company six 
years after the first investment, the company really has only about two years to develop a 
saleable product and four years to develop the requisite $20M in annual revenues. 
 
Most university and national lab IP and ideas are not ready for a two-year product development 
cycle at the time we or Battelle Ventures show up.  Rather, they may need six to eighteen months 
of help to bridge that gap from the 20 to 50 yard line.  We may provide that gap-filling or 
maturation funding, but with some very specific milestones.  Hence, the idea that a researcher 
has six or seven years to work on a business project is a misconception.  They have in fact had 
no more than two years in practice before the real world imposes market discipline. 
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At this point in time, Battelle Ventures I is on track with 16 companies so far in its portfolio, and 
plans to begin Battelle Ventures II are in the works. 
 
Technology Transfer at Oak Ridge National Laboratory 
 
Let’s turn to the national labs.  All five of the national labs we manage or co-manage for DOE 
have mechanisms to pursue technology transfer and commercialization.  The Pacific Northwest 
National Laboratory’s web site, for example, even features a designated link for “available 
technologies.”  In the interest of brevity and detail, however, I’m going to focus my discussion of 
lab-based technology transfer on ORNL. 
 
I should point out that our co-managing arrangement of ORNL is itself a partnership between the 
University of Tennessee and Battelle, together with formal board membership by six other 
Southeastern research universities.  Since UT-Battelle assumed management responsibilities, we 
have worked together to make ORNL not only a first-rate center for scientific research, but 
“business-friendly” as well. 
 
I’m confident we’re on the right track.  Alex Fischer, ORNL’s Director of Technology Transfer 
and Economic Development, who has had several years in the business and governmental worlds 
outside of the Laboratory, confirms that the Lab has “…started down the cultural journey…” 
that has encouraged “…our researchers’ willingness to talk about and engage in 
commercialization.”  This, of course, is without undue interference in their pursuit of more 
fundamental scientific endeavors which support the lab and the DOE mission. 
 
That “cultural journey” has been transformed into a “guided tour” of commercialization 
opportunities.  Since UT-Battelle became ORNL’s managing contractor in April, 2000, the Lab 
has developed a number of programs to encourage and assist affiliated start-up companies.  
Those programs include part- and full-time entrepreneurial leave, business assistance and, 
potentially, venture capital through Battelle Ventures and Innovation Valley Partners – a fund 
tethered side-by-side to Battelle Ventures. 
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ORNL also provides technology maturation funds to help prepare the inventions for licensure.  
Researchers have two sources of tech maturation funding: one is government dollars generated 
by revenues ORNL receives from previously licensed technologies, including royalties, and the 
other is “privately funded technology transfer,” (PFFT) funded by UT-Battelle, which receives 
the returns from a technology after it is licensed.  These private funds are sometimes 
supplemented by corporate dollars from Battelle and matching investments from the University 
of Tennessee, or direct funding by Battelle Ventures to help bridge the gap from idea to actual 
demonstration. 
 
In the past six years, ORNL has helped generate 61 start-ups.  Of those, 56 qualified to be part of 
a UT-Battelle-funded program called the “Center for Entrepreneurial Growth” which provides 
business counsel, financial planning, marketing assistance, and other aid to companies in their 
formative stages.  Of the 56 companies that have participated in the CEG since it began, 36 are 
still in business.   
 
For companies interested in accessing unique expertise or equipment to resolve their particular 
research challenge, ORNL offers three primary mechanisms.  First, if a potential industrial 
customer wants to contract with ORNL to solve some specific problem, a work-for-others 
agreement is likely to be the preferred mechanism.  Second, if an industrial firm wants to 
collaborate with ORNL and share in the costs of joint research, a cooperative research and 
development agreement, or “CRADA,” would be appropriate.  Third, if a company wants to send 
its own staff to use ORNL’s equipment and facilities to conduct experiments or characterize a 
material, they would probably enter into a user agreement.   
 
Currently, Battelle and Battelle Ventures offer an alternative way for interested parties to 
navigate a large number of laboratories at one time.  In many cases, Battelle Ventures will 
introduce an existing company to one or more labs so that Battelle or lab technology can be 
“inserted” and thereby accelerate its growth.  Often, an equity position is then taken for this 
contribution. 
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I, as well as others in this audience, am well aware of the current complexities of the DOE-
imposed processes.  Battelle and DOE continue to collaborate on improved processes that will 
foster even more access to the important assets by others. 
 
I’d like now to shift our discussion from our work with national labs to our university 
relationships, and I’ll focus specifically on our neighbor to the north in Columbus – OSU. 
 
Battelle and The Ohio State University: Neighbors and Collaborators   
 
As you’ve heard me say, Battelle is involved in alliances and collaborations with multiple 
colleges and universities, and probably none are more complex and far-reaching than those we 
have with The Ohio State University.  And OSU, like most major universities, is a tremendously 
powerful economic engine in its own right before the potential impact of research and IP 
commercialization is even considered.  Before we examine some of our collaborations, consider 
the effect an institution like OSU has on the local and the state-wide economy: 
 
•  As of the fall of 2004, OSU employed almost 23,000 Ohioans on both a full- and part-
time basis which represented a total payroll of over $1.6 billion annually.  This is in 
addition to the more than 12,000 part-time student employees whose wages exceeded 
$183 million. 
 
•  In fiscal year 2004, OSU purchased over $346 million in goods and services with more 
than $203 million of that going to Ohio vendors. 
 
•  Again, in fiscal year 2004, OSU spent more than $259 million on major construction 
projects with more than $225 million of than going to Ohio vendors. 
 
•  In addition to the “multiplier” effects of employee, student, and visitor spending, there’s 
another statistic especially relevant to our discussion.  According to U.S. Commerce 
Department Bureau of Economic Analysis estimates, every $l million expended supports   13
32 jobs in the local community.  That means OSU’s research and development programs 
representing half a billion dollars per year support more than 17,000 jobs. 
 
These statistics confirm the substantial “baseline” impact a major university has on its local and 
regional economies.  However, the research expertise and resources available at an institution 
like OSU are potential economic development “muscles” that have yet to be fully flexed.       
 
Battelle formalized a strategic relationship with The Ohio State University late in 2004.  Linking 
two of Columbus’s largest research assets enables both of us – Battelle and OSU – to share staff 
and facilities, engage in joint research projects, and pursue economic development projects that 
will generate benefits for Central Ohio and beyond.  Put simply, we can do more together than 
we can separately. 
 
Today, Battelle and OSU share more than 40 projects involving education, public policy, 
entrepreneurship, technology commercialization, homeland security, bioproducts, advanced 
cancer diagnostics and therapeutics, medicine, energy, and environmental issues.  As you might 
expect from that list, we’re working with several OSU colleges including Medicine, Agriculture, 
Engineering, Math/Physical Sciences, Business, and the Arts. 
 
We expect the long-term synergy created by the Battelle-OSU alliance to be permanent and far-
reaching.  For example, we anticipate using it to improve the regional environment for a robust 
research and technology workforce, to attract technology-oriented companies to Central Ohio, 
and to cultivate fertile ground for new companies to start up, grow, and thrive.  The Battelle-
OSU alliance is also one cornerstone of a local initiative which seeks to build a research and 
technology “corridor” along State Route 315 in Columbus. 
 
The “corridor” has already attracted nearly $78 million of public-private funding under the State 
of Ohio’s Third Frontier Program during the past three years, which includes: 
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•  The Ohio Bioproducts Innovation Center which will harness the ability of Ohio’s 
agricultural industry to produce high-value specialty chemicals from sustainable 
feedstocks (more about this in a moment); 
 
•  An advanced diagnostic/therapeutic program to develop new approaches for more 
effective  treatment and prevention of lung cancer; and 
 
•  The Cardiovascular Biomedical Enterprise, which is developing products to enable 
earlier detection and treatment of cardiovascular disease. 
 
In addition, nearly $40 million in new collaborative efforts were proposed at the close of 2005, 
including: 
 
•  The Food Safety and Biosecurity Center (to be located at OSU), which would bring 
government, academia, and industry together to protect our nation’s food pipeline and – 
in the process – leverage the presence of nearly 1,000 agri-business entities in Ohio; and 
 
•  The Personalized Medicine Center for Acute and Chronic Disease (also to be located at 
OSU), which will synthesize medical records information and post-genomic research to 
serve as a trusted clearinghouse for health care providers. 
 
Nanotechnology: Another Industry and Academic Alliance 
 
We also participate with OSU and other universities in research and development alliances 
which focus on nanotechnology platforms.  Our collaboration with universities, industry, and 
other organizations supports the National Nanotechnology Initiative (NNI) in its effort to 
advance nanoscience and commercialize new products.  We’ve assembled a Battelle 
Nanotechnology Innovation Alliance which includes: 
 
•  National Renewable Energy Laboratory; 
•  The Center for Nanophase Materials Sciences at Oak Ridge National Laboratory;   15
•  The ESML Interfacial and Nanoscale Science Facility at the Pacific Northwest 
National Laboratory; 
•  Idaho National Laboratory; and 
•  Battelle’s R&D labs in Columbus, Ohio. 
 
The Alliance is succeeding on many fronts.  For example, in 2005, the Alliance supported OSU, 
the University of Akron, and the University of Dayton to win a $22 million grant from the State 
of Ohio to establish the Center for Multifunctional Polymer Nanomaterials and Devices. 
 
Another linkage with OSU resulted in an $11.6 million grant to establish the Ohio BioProducts 
Innovation Center which I mentioned earlier.    The Innovation Center is a collaboration of 
industry and academic research dedicated to creating new materials solutions for the chemical 
and plastics industries using renewables like corn and soybeans.  OSU leads the Center’s 
academic consortium which includes 11 Ohio institutions of higher learning and six additional 
universities from other states.   
 
This year, the Battelle Nanotechnology Innovation Alliance is working with OSU, the University 
of Toledo, Bowling Green State University, the five national labs we manage or co-manage, and 
several companies to establish a Center for Photovoltaics Innovation and Commercialization that 




For more than 75 years, Battelle has marshaled science and technology to produce practical 
innovations and solutions with “real-world” applications.  Our collaborations with national labs 
and colleges and universities have been an integral part of that process, both in the U.S. and 
overseas.  Most recently, this has culminated in a joint venture in Japan, and a research 
organization with Korea University called “Battelle at KU.” 
 
Collaborations, in fact, will assume an increasingly larger role in bringing new ideas and 
technologies to the marketplace.  In a world where communication, access to intellectual   16
property, and the movement of capital are almost instantaneous, no organization can be entirely 
self-sufficient; collaborations and alliances play to the strengths of the participants. 
 
Our nation’s leadership, and perhaps even our economic viability, depends on the willingness 
and ability of businesses, industries, research institutions, and colleges and universities to work 
together.  Collaborative excellence at the intersections of science, technology, and the 
marketplace holds the key to our future. 
 
Thank you for inviting me to participate in this Federal Reserve Conference.  I’ll be happy to 
address any questions you may have. 
 
  